Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2018-11-21 Major Shareholding Noti…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
181121 - Transparency Nov 21 2018 ENG.pdf
Major Shareholding Notification Classification · 98% confidence The document is a 'Transparency notification' received by UCB SA/NV from BlackRock, Inc. It details changes in BlackRock's holding of UCB shares, specifically noting when the holding crossed the 5% threshold upwards (on Nov 15, 2018) and then crossed downwards (on Nov 16, 2018). This type of filing, which reports changes in significant share ownership or voting rights by an individual or entity, directly corresponds to the definition of a Major Shareholding Notification (MRQ). It is not an Annual Report (10-K), an Earnings Release (ER), or a Director's Dealing (DIRS), as it concerns a major institutional shareholder's stake, not an executive's personal trade or a full financial report.
2018-11-21 English
181121 - Transparency Nov 21 2018 FR.pdf
Major Shareholding Notification Classification · 99% confidence The document is a formal notification from UCB SA announcing that BlackRock, Inc. has submitted two transparency declarations regarding changes in its significant shareholding in UCB. Specifically, it details crossing the 5% threshold upwards on November 15, 2018, and crossing it downwards on November 16, 2018. This type of filing, which reports changes in significant ownership thresholds (crossing above or below a set percentage, like 5%), directly corresponds to the definition of a Major Shareholding Notification. The key indicators are: 1. Mention of 'déclarations de transparence' (transparency declarations). 2. Specific mention of 'Seuil franchi : 5%' (Threshold crossed: 5%). 3. Detailed breakdown of voting rights and financial instruments held by various BlackRock entities. This matches the definition for Major Shareholding Notification (MRQ).
2018-11-21 French
181121 - Transparency Nov 21 2018 NL.pdf
Major Shareholding Notification Classification · 99% confidence The document is titled "Transparantieverklaringen BlackRock, Inc." (Transparency Declarations BlackRock, Inc.) and explicitly mentions receiving two notifications regarding the crossing of a 5% threshold of voting rights in UCB NV, citing Article 14 of the Belgian law of May 2, 2007, on the disclosure of major shareholdings. This content—the disclosure of changes in significant share ownership crossing regulatory thresholds—directly corresponds to the definition of a Major Shareholding Notification. The key indicators are: 1. Mention of 'kennisgevingen' (notifications) regarding shareholdings. 2. Specific mention of crossing the '5% drempel' (5% threshold). 3. Detailed tables showing the number of voting rights and financial instruments held by various BlackRock entities. This aligns perfectly with the definition for Major Shareholding Notification (Code: MRQ). It is not an Earnings Release (ER), Annual Report (10-K), or a general Regulatory Filing (RNS), as it concerns a specific type of mandatory disclosure regarding ownership structure.
2018-11-21 Dutch
UCB_9m 2018_Final_ENG.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'UCB First Nine Months Interim Report 2018' and contains detailed financial performance data, including revenue breakdowns, product sales tables, and financial outlooks for the 2018 fiscal year. It provides substantive financial analysis rather than just a summary or an announcement of a report's availability. Therefore, it is classified as an Interim/Quarterly Report. 9M 2018
2018-10-30 English
UCB_9m 2018_Final_FR.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a 'Rapport intermédiaire' (Interim Report) for UCB covering the first nine months (9M) of 2018. It contains detailed financial tables, revenue breakdowns by product and region, R&D updates, and management commentary on financial performance. It is not a mere announcement of a report, as it provides substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report (IR). 9M 2018
2018-10-30 French
UCB_9m 2018_Final NL.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a quarterly financial update from UCB for the first nine months of 2018. It contains detailed financial tables (revenue, product performance), management commentary on business trends, R&D updates, and financial outlooks. It is not a mere announcement of a report (RPA) as it provides substantive financial data and analysis. It fits the definition of an Interim/Quarterly Report (IR) as it covers a period shorter than a full fiscal year and includes actual financial statements and analysis. 9M 2018
2018-10-30 Dutch

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.